Voltage-gated sodium channels, potential targets of Tripterygium wilfordii Hook. f. to exert activity and produce toxicity

Bai, 2003, Effects of demethylzeylasteral and celastrol on spermatogenic cell Ca2+ channels and progesterone-induced sperm acrosome reaction, Eur. J. Pharmacol., 464, 9, 10.1016/S0014-2999(03)01351-7 Blechschmidt, 2008, Voltage-gated Na+ channel transcript patterns in the mammalian heart are species-dependent, Prog. Biophys. Mol. Biol., 98, 309, 10.1016/j.pbiomolbio.2009.01.009 Cai, 2015, Tripterygium glycosides inhibit inflammatory mediators in the rat synovial RSC-364 cell line stimulated with interleukin-1beta, Biomed. Rep., 3, 763, 10.3892/br.2015.501 Cascão, 2017, Celastrol: a spectrum of treatment opportunities in chronic diseases, Front. Med., 4, 69, 10.3389/fmed.2017.00069 Chang, 1999, Effects of anti-rheumatic herbal medicines on cellular adhesion molecules, Ann. Rheum. Dis., 58, 366, 10.1136/ard.58.6.366 Cox, 2006, An SCN9A channelopathy causes congenital inability to experience pain, Nature, 444, 894, 10.1038/nature05413 Goldberg, 2007, Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations, Clin. Genet., 71, 311, 10.1111/j.1399-0004.2007.00790.x Huang, 2009, Pathological study on autopsy died of Tripterygium intoxication--report of 4 cases, Zhongguo Zhong Xi Yi Jie He Za Zhi, 29, 165 Kanters, 2014, Flecainide provocation reveals concealed brugada syndrome in a long QT syndrome family with a novel L1786Q mutation in SCN5A, Circ. J., 78, 1136, 10.1253/circj.CJ-13-1167 Li, 2011, Literature investigation and analysis of 294 cases of adverse reactions of Tripterygium wilfordii, Shanxi. Medical. Journal., 1, 88 Matta, 2009, Triptolide induces anti-inflammatory cellular responses, Am. J. Transl. Res., 1, 267 Meregalli, 2009, Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies, Heart Rhythm, 6, 341, 10.1016/j.hrthm.2008.11.009 Shan, 2016, Effect of Tripterygium wilfordii polyglycoside on experimental prostatitis caused by ureaplasma urealyticum in rats, Med. Sci. Monit., 22, 3722, 10.12659/MSM.897360 Shen, 2015, (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway, BMC Compl. Alternative Med., 15, 77, 10.1186/s12906-015-0566-y Sun, 2006, Chronic inhibition of cardiac Kir2.1 and HERG potassium channels by celastrol with dual effects on both ion conductivity and protein trafficking, J. Biol. Chem., 281, 5877, 10.1074/jbc.M600072200 Sun, 2022, Prediction and verification of potential lead analgesic and antiarrhythmic components in Corydalis yanhusuo W. T. Wang based on voltage-gated sodium channel proteins, Int. J. Biol. Macromol., 216, 537, 10.1016/j.ijbiomac.2022.07.024 Veldkamp, 2003, Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families, Circ. Res., 92, 976, 10.1161/01.RES.0000069689.09869.A8 Vetter, 2017, NaV1.7 as a pain target - from gene to pharmacology, Pharmacol. Ther., 172, 73, 10.1016/j.pharmthera.2016.11.015 Wang, 2017, Tripterygium wilfordii glycosides upregulate the new anti-inflammatory cytokine IL-37 through ERK1/2 and p38 MAPK signal pathways, Vid. Based. Complement. Alternat. Med., 10.1155/2017/9148523 Wu, 1994, 1 case of arrhythmia caused by Tripterygium wilfordii poisoning, Heilongjiang. J. Tradit. Chin. Med., 5, 44 Xu, 2021, Active components of Bupleurum chinense and Angelica biserrata showed analgesic effects in formalin induced pain by acting on Nav1.7, J. Ethnopharmacol., 269, 10.1016/j.jep.2020.113736 Yang, 2010, Effect of triptolide on secretion of inflammatory cellular factors TNF-alpha and IL-8 in peritoneal macrophages of mice activated by lipopolysaccharide. World, J. Emerg. Med., 1, 70 Zhao, 2019, Cardiac toxicity of Triptergium wilfordii Hook F. may correlate with its inhibition to hERG channel, Heliyon, 5, 10.1016/j.heliyon.2019.e02527 Zhou, 2014, Triptolide-induced oxidative stress involved with Nrf2 contribute to cardiomyocyte apoptosis through mitochondrial dependent pathways, Toxicol. Lett., 230, 454, 10.1016/j.toxlet.2014.08.017